FDA's Public Health Safeguarding

The U.S. Food and Drug Administration (FDA) has issued several alerts and guidances aimed at safeguarding public health.

Nutramigen Infant Formula Recall

Reckitt/Mead Johnson Nutrition voluntarily recalled specific batches of Nutramigen Hypoallergenic Infant Formula Powder due to potential Cronobacter sakazakii contamination. Although no illnesses have been reported, consumers are advised to cease use of the affected products and seek a refund.

Nutramigen Infant

Guidance on Benzene Levels in Drug Products

FDA released guidance to assist drug manufacturers in limiting benzene exposure in certain drug products, providing recommendations for testing and reformulation to ensure consumer safety.

Revised Guidance on Ophthalmic Drug Products

Revisions to the draft guidance for topical ophthalmic drug products include enhanced information on product sterility and preservative use, along with clarification on the scope of applicable products.

Alert on False Positive HSV-2 Test Results

Healthcare providers were reminded about the potential for false positive results in herpes simplex virus type 2 (HSV-2) serological tests, emphasizing the importance of accurate diagnosis and treatment.

Safety Alert for Contaminated Oysters

FDA issued a safety alert advising against the consumption of certain oysters from British Columbia, Canada, due to potential contamination with Campylobacter jejuni, urging restaurants and retailers to cease sales.

These recent actions underscore FDA's commitment to ensuring the safety and well-being of the public.

FDA

Table of Contents

• Nutramigen Infant Formula Recall
• Guidance on Benzene Levels in Drug Products
• Revised Guidance on Ophthalmic Drug Products
• Alert on False Positive HSV-2 Test Results
• Safety Alert for Contaminated Oysters